Uncategorized

IVERIC bio to Present at the Chardan Capital Markets 3rd Annual Genetic Medicines Conference

by Business Wire • 2019/09/30 • 0 Comments

NEW YORK--(BUSINESS WIRE)--IVERIC bio announced that Glenn P. Sblendorio, CEO and President, will present an overview of the Company at the Chardan Genetic Medicines Conference.

Full Story →

← Ocugen Announces Completion of its Merger with Histogenics to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics

Ocugen and CanSinoBIO Enter Strategic Partnership for Gene Therapy Co-Development and Manufacturing →

Post navigation